Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression
Multiple Principal Investigator (contact): Cathy J. Reback, Ph.D.
Multiple Principal Investigator: Sean Murphy, Ph.D. Weill Cornell Medical College
Co-Investigator: Thomas Blue, Ph.D., Friends Research Institute
Co-Investigator: Ali Jalali, Ph.D., Weill Cornell Medical College
Co-Investigator: Raphael J. Landovitz, MD, MSc, University of California, Los Angeles
Research Coordinator: Ray Mata
Funded By: National Institute on Drug Abuse
Grant #: R01DA056287
Total Project Period: 8/15/23 – 6/30/28
[Abstract]

Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
Principal Investigator: Cathy J. Reback, Ph.D.
Co-Principal Investigator: Sean Murphy, Ph.D., Weill Cornell Medical College
Co-Investigator: Raphael J. Landovitz, MD, MSc, University of California, Los Angeles
Co-Investigator: David Benkeser, Ph.D., Emory University
Co-Investigator: Ali Jalali, Ph.D., Weill Cornell Medical College
Co-Investigator: Steve Shoptaw, Ph.D., University of California, Los Angeles
Research Coordinator: Ray Mata
Funded By: National Institute on Drug Abuse
Grant #: R01DA056888
Total Project Period: 9/01/22 – 6/30/27
[Abstract]